Michael L. Levitz

Michael L. Levitz

Former EVP, Chief Financial Officer and TreasureratAnika Therapeutics· In proxies 2021–2024

Pay in FY2024+7% from the year before · Anika Therapeutics stock -27.4% the same year

Michael L. Levitz was paid $1.8M in FY2024 (Dec), up 7%. Anika Therapeutics stock fell 27.4% that year.

Pay$100 in the stock at the end of FY20 → $36
Pay is from the Summary Compensation Table of each Anika Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anika TherapeuticsPublic company · 5 yr
    • Former EVP, Chief Financial Officer and Treasurer2021 – Present · 5 yrStock in role -50%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?